胺碘酮对充血性心力衰竭合并室性心律失常患者的效果观察

焦洁，郭剑

（陕西省神木县医院，陕西 榆林，719300）

浏览次数：86次 下载次数：347次

摘要：

目的 研究并探讨对充血性心力衰竭合并室性心律失常患者实施胺碘酮治疗的临床效果。方法 选取我院收治的100例充血性心力衰竭合并室性心律失常患者作为研究对象，采取数字随机表法将患者分为对照组和观察组，每组50例。对照组实施常规抗心衰治疗，观察组在对照组的基础上给予胺碘酮治疗。比较两组患者的临床总有效率，以及治疗前、后的LVEF、NT-proBNP、6min步行距离。结果 观察组的临床总有效率为96.00%，明显高于对照组的80.00%（P<0.05）。治疗后，两组患者 的LVEF、NT-proBNP、6min步行距离均较治疗前明显改善（P<0.05），且观察组明显优于对照组（P<0.05）。结论 胺碘酮治疗充血性心力衰竭合并室性心律失常具有显著的临床疗效，可有效改善患者的心功能。

关键词：充血性心力衰竭；室性心律失常；胺碘酮

中图分类号：R541.7文献标志码：A文章编号：2096-1413(2017)12-0047-02

Effect of amiodarone on patients with congestive heart failure complicated with ventricular arrhythmia
JIAO Jie, GUO Jian
(Shenmu County Hospital of Shaanxi Province, Yulin 719300, China)

ABSTRACT: Objective To study and to explore the effect of amiodarone on patients with congestive heart failure complicated with ventricular arrhythmia. Methods One hundred cases of patients with congestive heart failure complicated with ventricular arrhythmia were selected as the study objects, and they were divided into control group and observation group according to the digital random table method, with 50 cases in each group. The control group was given routine heart failure treatment, while the observation group was given amiodarone on the basis of the control group. The clinical total effective rate, and the left ventricular ejection fraction (LVEF), NT-proBNP, 6-minute walking distance of the two groups before and after treatment were compared. Results The total effective rate of the observation group was 96.00%, which was significantly higher than 80.00% of the control group (P<0.05). After treatment, the LVEF, NT-proBNP and 6-minute walking distance of the two groups were significantly improved (P<0.05), and the observation group was significantly better than those in the control group (P<0.05). Conclusion Amiodarone has significant clinical effect in the treatment of patients with congestive heart failure combined ventricular arrhythmia, which can effectively improve the cardiac function of patients.
KEYWORDS：congestive heart failure; ventricular arrhythmia; amiodarone

参考文献：
[1] 赵素贞.用胺碘酮对合并室性心律失常的充血性心力衰竭患者进行治疗的效果研究[J].当代医药论丛,2015,13(22):199-200.
[2] 赖汉齐,赖业旺,傅万颖,等.胺碘酮治疗充血性心力衰竭合并室性心律失常137例临床分析[J].河北医学,2013,19(6):884-887.
[3] 罗玉钊,陈炎,何洪,等.胺碘酮治疗充血性心力衰竭合并室性心律失常的效果[J].中国医药导报,2015,12(8):57-60.
[4] 姚朝阳.胺碘酮治疗充血性心力衰竭合并室性心律失常临床分析[J].河北医药,2014,36(16):2500-2501.
[5] 廖成标,乐建华,蒋爱忠,等.胺碘酮治疗充血性心力衰竭合并室性心律失常临床疗效分析[J].吉林医学,2016,37(7):1696-1697.
[6] 任等.胺碘酮治疗充血性心力衰竭合并室性心律失常临床观察[J].中国处方药,2016,14(4):62-63.
[7] 林能波.胺碘酮治疗充血性心力衰竭合并室性心律失常的临床疗效[J].河北医药,2011,33(13):1951-1952.
[8] 任学良,张吉廷,杨东,等.胺碘酮治疗充血性心力衰竭并室性心律失常临床疗效评价[J].西部医学,2012,24(12):2318-2320.
[9] 孟林英.胺碘酮治疗充血性心力衰竭心律失常34例[J].中国药业,2012,21(7):88-89.